1. Home
  2. ASMB

as 05-30-2024 9:42am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Founded: 2005 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 83.1M IPO Year: 2010
Target Price: N/A AVG Volume (30 days): 18.4K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -10.48 EPS Growth: N/A
52 Week Low/High: $7.68 - $20.04 Next Earning Date: 05-08-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Stock Insider Trading Activity of Assembly Biosciences Inc. (ASMB)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
White Nicole S ASMB Chief Manufacturing Officer Apr 29 '24 Sell $12.71 1,255 $15,947.03 13,025 SEC Form 4
McHutchison John G ASMB Director Apr 1 '24 Sell $13.07 1,206 $15,764.71 21,221 SEC Form 4
Bjorkquist Jeanette M ASMB Principal Accounting Officer Mar 29 '24 Sell $13.07 114 $1,490.20 3,166 SEC Form 4
Okazaki Jason A ASMB CEO and President Mar 29 '24 Sell $13.07 354 $4,627.45 13,826 SEC Form 4
Schornstein Alexander ASMB 10% Owner Jan 17 '24 Buy $0.78 299,994 $235,195.30 7,864,286 SEC Form 4
Schornstein Alexander ASMB 10% Owner Jan 17 '24 Buy $0.80 345,086 $276,068.80 8,209,372 SEC Form 4
Schornstein Alexander ASMB 10% Owner Nov 20 '23 Buy $0.72 300,000 $215,400.00 7,464,292 SEC Form 4
Schornstein Alexander ASMB 10% Owner Nov 20 '23 Buy $0.67 100,000 $66,700.00 7,564,292 SEC Form 4

Share on Social Networks: